Summit Therapeutics Inc. Quarterly Current Ratio in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Summit Therapeutics Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q3 2024.
  • Summit Therapeutics Inc. Current Ratio for the quarter ending September 30, 2024 was 482 %, a 34.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 482 -253 -34.4% Sep 30, 2024
Q2 2024 298 -1.2K -80.1% Jun 30, 2024
Q1 2024 463 -810 -63.6% Mar 31, 2024
Q4 2023 532 -510 -48.9% Dec 31, 2023
Q3 2023 735 +220 +42.7% Sep 30, 2023
Q2 2023 1.5K +1.06K +241% Jun 30, 2023
Q1 2023 1.27K +821 +182% Mar 31, 2023
Q4 2022 1.04K +731 +235% Dec 31, 2022
Q3 2022 515 +198 +62.4% Sep 30, 2022
Q2 2022 438 +148 +50.9% Jun 30, 2022
Q1 2022 452 +195 +75.9% Mar 31, 2022
Q4 2021 311 Dec 31, 2021
Q3 2021 317 Sep 30, 2021
Q2 2021 291 Jun 30, 2021
Q1 2021 257 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.